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Summary
The neural membrane glycoprotein PrP (prion protein)
has a key role in the development of scrapie and related
neurodegenerative diseases. During pathogenesis, PrP
accumulates in and around cells of the brain from which
it can be isolated in a disease-specific, protease-resistant
form. Although the involvement of PrP in the pathology
of these diseases has long been known, the normal
function of PrP remains unknown. Previous studies have
shown that the PrP gene is expressed tissue specifically in
adult animals, the highest levels in the brain, with
intermediate levels in heart and lung and low levels in
spleen. Prenatally, PrP mRNA has been detected in the
brain of rat and hamster just prior to birth. In this study
we have examined the expression of the PrP gene during
mouse embryonic development by in situ hybridisation
and observed dramatic regional and temporal gene
expression in the embryo. Transcripts were detected in
developing brain and spinal cord by 13.5 days. In
addition, PrP gene expression was detected in the
peripheral nervous system, in ganglia and nerve trunks
of the sympathetic nervous system and neural cell
populations of sensory organs. Expression of the PrP
gene was not limited to neuronal cells, but was also
detected in specific non-neuronal cell populations of the
13.5 and 16.5 day embryos and in extra-embryonic
tissues from 6.5 days. This cell-specific expression
suggests a pleiotropic role for PrP during development.
Key words. PrP gene, in situ hybridisation, mouse embryo.
Introduction
Scrapie, Creutzfeldt-Jakob disease and bovine spongi-
form encephalopathy are transmissible neurodegenera-
tive disorders associated with alterations in the neural
membrane protein PrP (Oesch et al., 1985; review:
Hope and Manson, 1991). In unaffected animals, PrP is
a protease-sensitive cell surface glycoprotein anchored
in the membrane by a glycoinositol phospholipid (Stahl
et al., 1987). During the course of these diseases PrP
aggregates and accumulates in and around cells of the
brain as protease-resistant deposits.
Allelic forms of PrP protein are associated with the
incidence of Gerstmann-Straussler (GSS) and Creutz-
feldt-Jakob disease (CJD) in humans (Doh-ura et al.,
1989; Collinge et al., 1989; Owen et al., 1990) and
amino acid differences in PrP have been linked to
different incubation periods of scrapie in mice
(Westaway et al., 1987), hamsters (Lowenstein et al.,
1990) and sheep (Goldmann et al., 1991). Recent
experiments have shown that transgenic mice express-
ing multiple copies of a mutant PrP associated with GSS
develop a spontaneous neurodegenerative disease with
similar pathology to GSS (Scott et al., 1989; Hsiao et
al., 1990).
Although the involvement of PrP in the pathology of
these diseases is now well documented and a role for
PrP in their transmissibility is suspected, the normal
function of PrP is not known. The conservation of PrP
structure in mammalian species suggests an important
role for PrP in cell metabolism. Its location on the
neural cell membrane has led to suggestions that, like
the N-CAMs and cadhedrins, it may function as a
neural cell receptor or as a cell adhesion molecule
directing and/or maintaining the architecture of the
nervous system (Hope and Manson, 1991). Others have
suggested PrP may be an astroglial cell proliferation
factor, based on the production of a GFAP-stimulating
factor in cultured cell lines from CJD-infected brains
(Oleszak et al., 1988) and the gliosis which occurs
during the development of neurodegenerative trans-
missible diseases (DeArmond et al., 1987).
PrP is expressed in specific tissues of adult animals.
High levels of PrP mRNA have been detected by
Northern analysis in the brain, intermediate levels are
found in heart and lung of hamsters and mice, whereas
liver and spleen have low or barely detectable levels
(Oesch et al., 1985; Caughey et al., 1988). In situ
hybridisation studies have indicated that expression of
PrP within the brain is limited to the neuronal cells
(Kretzschmar et al., 1986; Manson et al., 1992). The
DNA sequences and trans-acting factors involved in
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tissue-specific PrP gene expression have not yet been
identified, but there is evidence that nerve growth
factor may increase the level of PrP mRNA in both in
vivo (Mobley et al., 1988) and in vitro studies (Wion et
al., 1988). This may indicate a role for PrP in neuronal
differentiation or survival.
Postnatally, PrP gene expression has been shown to
be developmentally regulated in the brain. Levels of
PrP mRNA were found to increase in the brain during
the immediate postnatal period in the hamster (McKin-
ley et al., 1987; Mobley et al., 1988) and in the rat
(Liederburg, 1987). In mouse brain, PrP mRNA was
detectable at birth and increased 4-fold from birth to
day 20 to a level which was maintained throughout adult
life (Lazarini et al., 1991). Differential timing of PrP
gene expression in different regions of hamster brain
has also been shown (Mobley et al., 1988). Early
postnatal expression was found in the brainstem and
neocortex, intermediate expression in the hippocampus
and thalamus and delayed expression in the septum
(basal forebrain). Previous studies have either failed to
detect PrP mRNA prenatally (McKinley et al., 1987) or
detected it only in the brain immediately before birth
(Mobley et al., 1988; Liederburg, 1987).
In order to establish the developmental timing of PrP
expression and to address whether PrP has a function in
embryonic development, we have examined the ex-
pression of PrP by in situ hybridisation in mouse
embryos. This study has shown that the PrP gene is
transcribed both tissue specifically and temporally
during embryonic development. Transcripts were not
only detected by 13.5 days in the developing brain and
spinal cord but were also found in the peripheral
nervous system. Detection of PrP transcripts in specific
non-neuronal cells and in extra-embryonic tissues
suggests a pleiotropic role for PrP during embryogen-
esis.
Materials and methods
Embryos
All embryos were derived from matings between
(C57BL/WsxCBA/Ca) Fl mice Embryonic age was deter-
mined according to vaginal plug (day 0.5). Embryos were
fixed overnight in periodate-lysine paraformaldehyde (2%),
dehydrated with ethanols and impregnated in wax during a 16
hour processing cycle. Sagittal and transverse sections of 6 /an
thickness from 6.5, 9.5, 13.5 and 16.5 day embryos were
mounted on slides coated with Vectabond (Vector labora-
tories). At least 3 embryos were examined at each stage of
development.
Probes for in situ hybridisation
Probe A was prepared by subcloning a 900 bp Kpnl-EcoBJ
fragment from exon 2 of the mouse PrP gene (from D.
Westaway) into T3T718U phagemid (Pharmacia Ltd). T7 and
T3 polymerase were used to synthesise both strands of RNA
from the construct after linearisation with the appropriate
restriction enzyme. -"S-UTP (Amersham International, 410
Ci/mmol) was incorporated into the single stranded RNA
molecules synthesised. The RNA strands were reduced to
fragments of approximately 150 bp by incubation in bicarbon-
ate buffer at 60°C. All results were confirmed using RNA
synthesised from a different subclone from exon 2 of PrP, a
136 bp PvuU fragment cloned into T3T718U phagemid (probe
C) (Manson et al., 1992). The specificity of the probes was
confirmed by genomic Southern and Northern blot analysis
(results not shown).
In situ hybridisation
Slides were deparaffinised, fixed in 4% paraformaldehyde,
digested with proteinase K and acetylated with tnethanol-
amme. The slides were then dehydrated and hybridised with
lxlO6 cts/min of 35S-labelled nboprobe at 55°C overnight.
Sense and antisense RNA probes were used on adjacent
sections. The slides were washed in hybridisation buffer at
55°C for one hour, treated with ribonuclease A at 37°C for 30
minutes and rinsed in 2xSSC/0.1xSSC and dehydrated
(Davidson et al., 1988). The slides were dipped in Ilford K5
emulsion dried and stored for 7-21 days at 4°C. The slides
were developed, air dried and stained with Giemsa.
Results
In situ localisation of PrP in mouse embryos
PrP RNA was detected in sections of mouse embryos
using in situ hybridisation with 35S-labelled single
stranded RNA probes derived from a mouse genomic
clone of PrP (Westaway et al., 1987). Sense is used to
describe transcripts which are identical to the primary
transcripts of the PrP gene and antisense indicates the
complementary orientation which therefore hybridises
with the primary transcript.
Initially the hybridisation pattern was characterised
using probe A derived from exon 2 of the mouse PrP
gene. All results were confirmed using single stranded
RNA derived from probe C which contains a different
PrP sequence to probe A (Manson et al., 1992). Sagittal
and transverse serial sections were hybridised to sense
or antisense RNA and hybrids were detected with
nuclear track emulsion and autoradiography.
PrP gene expression in the CNS
No PrP transcripts could be detected by in situ
hybridisation in 6.5 or 9.5 day old mouse embryos but
by 13.5 days expression of the PrP gene was wide-
spread. Transcripts were found both within the CNS
and in specific areas outside the CNS of the developing
mouse (Fig. 1A). PrP gene expression was detected
throughout the developing brain in both the 13.5 and
16.5 day embryos, in the olfactory lobe, the telencepha-
lic cortex of the forebrain, the mantle and ventricular
zones of the mesencephalon and the rhombencephalon
and in the mantle layer of the spinal cord. Proliferation
zones of undifferentiated cell populations and regions
containing differentiated neuronal and glial cells
throughout the brain were therefore shown to express
the PrP gene.
The peripheral nervous system
PrP transcripts were detected in ganglia and nerves of
both the central and peripheral nervous systems.
Transcripts were detected in cranial and sympathetic
ganglia including the trigeminal ganglion (fifth cranial
Fig. 2. PrP gene expression was
detected in the CNS and peripheral
nervous system by in situ
hybridisation and bright field
microscopy. (A) PrP transcripts
were detected in the superior
cervical sympathetic ganglion of a
16.5 day embryo hybridised with
the antisense RNA probe. PrP
transcripts were also detected in
(C) dorsal root ganglia where large
numbers of silver grains were
associated with the large neuronal
cells and (E) in the trigeminal
ganglion (fifth cranial nerve). In
this section hybridisation was also
detected in the pituitary situated to
the right of the trigeminal ganglion
and in the brain Hybridisation
with the antisense RNA probe also
detected PrP transcripts throughout
nerve axons of both the CNS and
peripheral nervous system, clearly
seen here (G) in the optic nerve
(second cranial nerve). (B,D,F,H)
Adjacent sections hybridised with
the sense RNA probe showed only
background hybridisation.
Magnification, approx. x25.
Fig. 3. PrP gene expression was
detected associated with neural cell
populations of sense organs and the
intestine. In a 16.5 day embryo,
hybridisation was detected using
the antisense RNA probe (A) in
the epithelium of the olfactory
system where it was localised to the
region containing large numbers of
neurones. Hybridisation was also
detected using the antisense RNA
probe (C) in the extensive
submucous nerve plexus on the
dorsum of the tongue and (E) in
the inner nuclear layer of
developing neurones in the retina.
The pigment layer of the retina is
unlabelled but contains large
numbers of pigment granules which
give the appearance of
hybridisation. Only background
hybridisation was detected using
the sense RNA probes on adjacent
sections of (B) the olfactory
mucosa of the 16.5 day, (D) the
tongue of the 16.5 day embryo and
(F) the retina. The sections were
stained with Giemsa and examined
by bright field microscopy.
Magnification, approx. x25.
Fig. 4. PrP gene expression was detected in non-neuronal cell populations.
Hybridisation was detected in a 16.5 day embryo, using the antisense RNA probe
and bright field microscopy (A) in inner and outer epithelium layers of the tooth
primordium and (C) the developing metanephric cap derivatives of the kidney. The
PrP gene was also expressed in extra-embryonic tissue. PrP transcripts were
detected (E) in the maternal decidua and (G) the amnion, mesodermal layer of the
yolk sac and the umbilical cord of a 16.5 day conceptus. (B,D,F,H). Only
background hybridisation was detected using the sense RNA probe on adjacent
sections. Magnification approx. x25.
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Fig. 1. Expression of the PrP gene in 13.5 day mouse embryo detected by in situ hybridisation (A) Dark field microscopy
was used to visualise sagittal sections hybridised with 35S-labelled antisense RNA probe. Expression of the PrP gene was
detected throughout the developing brain, in the telencephalic cortex of the forebrain and the mesencephalon,
rhombencephalon and mantle layer of the spinal cord. Hybridisation was also clearly detectable in the optic nerve, the
superior cervical sympathetic ganglia, sympathetic trunks and the submucosal layers of the intestine 1, rhombencephalon;
2, superior cervical sympathetic ganglion; 3, sympathetic trunk and ganglia; 4, spinal cord, 5, gastro-duodenal junction; 6,
midgut within physiological umbilical hernia; 7, olfactory epithelium; 8, olfactory lobe; 9, optic nerve; 10, telencephalic
cortex; 11, mesencephalon. (B) Only background hybridisation was detected using the 35S-labelled sense RNA probe.
nerve) (Fig. 2E), the superior cervical sympathetic
ganglion (Fig. 2A) and sympathetic trunk and ganglia
(Fig. 1). Hybridisation was also detected throughout
dorsal root ganglia but the highest numbers of silver
grains were located over large neuronal cells (Fig. 2C).
Axons of cranial nerves, most strikingly the optic nerve
(Fig. 2G) and spinal nerves (Fig. 1) as well as in the
sympathetic nerve trunks, were also found to contain
PrP transcripts. The PrP gene may be expressed in the
glial cells which surround these axons or alternatively,
PrP mRNA could be transported from the neural cell
body through the axons. Recent studies have contra-
dicted the widely held view that axons do not contain
mRNA. There is evidence for transport of vasopressin
and oxytocin mRNA along axons from the hypothala-
mus to the nerve terminals of the posterior pituitary
(Mohr et al., 1991). Whether ribosomes are also found
within these axons to allow translation of the mRNA
remains to be established.
PrP gene expression in sense organs
Neuronal cell populations are candidates for expression
of the PrP gene within several organs. In the olfactory
epithelium (Fig. 3A) hybridisation was detected at both
13.5 and 16.5 days and was associated with the nervous
layer containing large numbers of sensory neurones.
Hybridisation was also detected at both 13.5 and 16.5
days in the tongue. The transcripts appear to be
associated in the extensive submucosal nerve plexus on
the dorsum of the tongue (Fig. 3C). Transcripts were
detected in the retina by 16.5 days and were associated
with the inner nuclear layer of differentiating neural
cells (Fig. 3E), whereas at 13.5 days only a diffuse low
level of hybridisation could be detected in the retina.
The intestine
PrP gene expression was also detected within the
submucosal and muscularis mucosa layers of the
intestine. Hybridisation in the intestine could be
detected at both 13.5 (Fig. 1) and 16.5 days. Transcripts
in these regions of the intestine may be associated with
the sympathetic plexus (and possibly also parasympath-
etic ganglia) in this location.
Non-neuronal cells expressing PrP gene
The PrP gene is expressed in non-neuronal cells. At
13.5 days PrP gene expression was detected in early
stages of differentiation of dental lamina. By 16.5 days,
hybridisation in tooth buds was higher than in any other
area of the embryo and was present in both inner and
outer epithelial layers (Fig. 4A), which give rise to the
enamel-forming cells. PrP gene expression was also
detected in specific cells of the kidney in the 16.5 day
embryo (Fig. 4C). The cells expressing PrP in the
kidney are in the early stages of differentiation into the
embryonic nephron. These cells have also been shown
to express nerve growth factor receptor during rat
embryogenesis (Sanola et al., 1991), which is consistent
with a regulatory role for NGF in PrP expression in the
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Trophoblast
giant cell
Reichert's
membrane
Amnion
Fig. 5. Diagram of 16.5 day mouse placenta showing outer layer of maternal decidua (D) plus the spongiotrophoblast (S)
and labyrinthine trophoblast (L) layers, both of which are derived from the zygote. Secondary trophoblast giant cells
(shown as filled circles) are found at the boundary between the maternal and 'fetal' parts of the placenta. The umbilical
cord (U) and three extra-embryonic membranes (Reichert's membrane, visceral yolk sac and amnion) are attached to the
inner part of the placenta as shown. PrP expression was found in the regions that are shaded dark grey (maternal decidua,
umbilical cord, amnion and yolk sac mesoderm), which are all derivatives of the primitive ectoderm lineage.
embryo as well as in the adult (Mobley et al., 1988;
Wion et al., 1988).
PrP gene expression in extra-embryonic tissue
The PrP transcripts were detected in maternal decidual
cells surrounding the embryos and their membranes at
the earliest stage examined, 6.5 days and 8.5 days. By
13.5 days PrP transcripts could be detected in the
maternal cells of the placenta and expression in these
cells could also be detected in the 16.5 day embryo (Figs
4E and 5). Expression of the PrP gene was also detected
in other extra-embryonic tissues of the 13.5 and 16.5
day conceptus. The amnion, umbilical cord and the
mesodermal layer of the yolk sac all hybridised to the
PrP probe (Fig. 4G). Thus expression in the extra-
embryonic membranes occurs in derivatives of the
primitive ectoderm lineage, which also produces the
entire fetus, but is absent from the derivatives of the
primitive endoderm (Reichert's membrane and yolk sac
endoderm) and trophectoderm (placental trophoblast).
A diagrammatic representation of the extra-embryonic
hybridisation detected at 16.5 days is shown in Fig. 5.
Anti-PrP
In all experiments adjacent sections were hybridised to
sense PrP probes (Figs 2-4). No evidence for any
expression from an anti-PrP gene (Goldgaber, 1991)
was obtained in these sections. Due to the limits of
sensitivity of in situ hybridisation, this result clearly
does not rule out the presence of such transcripts but
suggests if they are present it is at a very low level
(Manson and Hope, 1991; Hewinson et al., 1991;
Manson et al., 1992).
Discussion
PrP gene expression has been detected throughout the
developing neural tube from 13.5 days of development
in mouse embryos. The expression of PrP did not
appear to be restricted to areas of differentiated neural
cells but its widespread expression throughout the brain
suggests that PrP transcripts were also present in
undifferentiated cell populations. The PrP gene con-
tinues to be expressed in most if not all of the neurones
of the adult brain. High levels are found in the
pyramidal and dentate granular cells of the hippocam-
pus, Purkinje cells of the cerebellum and in large
neurones of the cortex, medulla and septum (Kretzsch-
mar et al., 1986; Manson et al., 1992). The expression of
the PrP gene in the developing neural tube and its
continued expression in the adult brain suggests that
PrP may be critical to neural function in the mammalian
central nervous system. PrP protein is located on the
outside of the neural cell membrane, attached by a
glycoinositol phospholipid (GIP) anchor (Stahl et al.,
1987). As a neuronal surface glycoprotein, it may be
involved in interactions between cells or with extra-
cellular matrix proteins. This would be similar to the
role proposed for the A4 amyloid precursor protein,
another membrane glycoprotein, implicated in the
onset of amyloidosis and dementia (Shivers et al.,
1988). Such interactions may be required to promote
neuronal cell differentiation during development of the
CNS and to maintain neuronal cell function in the
differentiated neurones.
PrP gene expression was not limited to the CNS.
Transcripts were also detected in ganglia and nerves of
the sympathetic nervous system and in neuronal cell
populations of the sensory organs. The role of PrP in
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neuronal differentiation or function does not appear to
be limited to the CNS but may have a similar function
throughout the peripheral nervous system. In early
postnatal development, PrP gene expression can be
regulated by nerve growth factor (Mobley et al., 1988)
which has been ascribed a role in CNS, sensory and
sympathetic neuronal survival (Williams et al., 1986;
Kromer, 1987). Conversely, the accumulation of PrP in
scrapie and related diseases is associated with neurone
loss in the CNS (DeArmond et al., 1987; Bruce et al.,
1989). PrP may therefore be involved in complex
pathways which determine neurone fate. Its expression
or aberrant metabolism may result in either neuronal
death or survival, during the development of the central
and peripheral nervous systems.
A further link between PrP gene expression and NGF
is indicated by the expression of PrP in the embryonic
nephrons of the kidney at the same time that NGF
receptor expression has been shown in rat embryonic
nephrons (Sariola et al., 1991). The function of PrP in
these cells and elsewhere may be to provide cell-cell
adhesion at sites of morphogenesis during develop-
ment. Alternatively PrP may be part of a cell signalling
system required for the differentiation of specific cells.
It may be that different mature forms of the PrP
protein are found in different cell types of the
developing embryo, resulting in altered cellular lo-
cations and functions of the protein. In adult lung and
heart a second mRNA, smaller than the more abundant
2.4 kb mRNA, has been detected (Robakis et al., 1986)
which allows for the possibility of different protein
forms of PrP in these tissues.
The widespread expression of PrP during mouse
embryogenesis revealed in this study suggests that
understanding the function of PrP will provide not only
insight into events which lead to neurodegeneration and
transmission of scrapie-like diseases but will also allow
investigation of fundamental developmental processes
during mouse embryogenesis.
We thank D. Westaway for the mouse PrP genomic clone,
D. Davidson for his help with in situ hybridisation and J.
Morgan and L. Doughty for photography and T. Pinner for
preparing figure 5.
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Note added in proof
Targetted deletion of the PrP gene from embryonic
stem cells by homologous recombination has allowed
the production of mice (Prn-pO//°) in which the PrP gene
is absent (Beuler et al., Nature in press). These mice
develop and behave normally with no apparent defects.
This shows other proteins may be able to take over the
pleiotropic functions of PrP in the Prn-pO//o mouse.
